EUVIMEDEUVIMED entdecken
Crossref

Distinct metabolic subtypes of gastric cancer: Immune profiles, therapeutic response prediction, and a 60-gene classifier

Silin Liu, Yusheng Luo, Chaoxun Dou, Yuling Huang, Qingyang Lin, Yin Huang, Zhuoming Guo, Fen Pan, Jinyan Guo

Eurasian Journal of Medicine and Oncology · 19.05.2026 · 026030024

DOI: 10.36922/ejmo026030024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 19.05.2026. Verfasst von Silin Liu und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metabolic reprogramming influences cancer progression and the immune microenvironment. In gastric cancer (GC), metabolic states may impact immune responses and treatment outcomes, but specific metabolic subtypes remain poorly characterized.

Objective

This study investigated metabolic subtypes and their immune features in GC and developed a gene classifier for clinical use.

Methods

Transcriptomic profiling via RNA sequencing, together with clinical data from 981 GC patients, was analyzed and independently validated using two external datasets (TCGA-STAD cohort and GSE113255). Non-negative matrix factorization identified two metabolic subtypes (clusters 1 and 2) based on metabolic gene expression. We compared clinical features, genomic alterations, immune profiles, and drug responses between subtypes and developed a 60-gene classifier using a support vector machine model.

Results

Cluster 1 was associated with poor prognosis, a low mutation burden, immune exclusion, high stromal activity, and dense immune infiltration; this subtype demonstrated increased sensitivity to platinum-based therapies. In contrast, cluster 2 was characterized by better clinical outcomes, an immune-inflamed phenotype, elevated programmed death-ligand 1 and cytokine expression, and a greater potential for responding to immunotherapy.

Conclusion

Our metabolic classification delineates distinct GC subtypes that hold significant implications for prognosis and therapy. The 60-gene classifier offers a practical tool for the clinical identification of these subtypes, which could enhance the precision of immunotherapy and chemotherapy strategies tailored to GC patients.

Zitieren

APA

Liu, S., Luo, Y., Dou, C., Huang, Y., Lin, Q., Huang, Y., Guo, Z., Pan, F., & Guo, J. (2026). Distinct metabolic subtypes of gastric cancer: Immune profiles, therapeutic response prediction, and a 60-gene classifier. Eurasian Journal of Medicine and Oncology, 0(0), 026030024. https://doi.org/10.36922/ejmo026030024

Vancouver

Liu S, Luo Y, Dou C, Huang Y, Lin Q, Huang Y, et al. Distinct metabolic subtypes of gastric cancer: Immune profiles, therapeutic response prediction, and a 60-gene classifier. Eurasian Journal of Medicine and Oncology. 2026;0(0):026030024. doi:10.36922/ejmo026030024

BibTeX
@article{Liu2026,
  author = {Liu, Silin and Luo, Yusheng and Dou, Chaoxun and Huang, Yuling and Lin, Qingyang and Huang, Yin and Guo, Zhuoming and Pan, Fen and Guo, Jinyan},
  title = {Distinct metabolic subtypes of gastric cancer: Immune profiles, therapeutic response prediction, and a 60-gene classifier},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026030024},
  doi = {10.36922/ejmo026030024}
}
Kostenlos starten →